• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

SOD1(G93A)转基因小鼠步态异常的演变。

Evolution of gait abnormalities in SOD1(G93A) transgenic mice.

机构信息

Group of Neuroplasticity and Regeneration, Institute of Neurosciences and Department of Cell Biology, Physiology and Immunology, Universitat Autònoma de Barcelona, and Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Bellaterra, Spain.

出版信息

Brain Res. 2011 Aug 11;1406:65-73. doi: 10.1016/j.brainres.2011.06.033. Epub 2011 Jul 5.

DOI:10.1016/j.brainres.2011.06.033
PMID:21733494
Abstract

Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disorder characterized by the loss of upper and lower motoneurons. Clinically, it is manifested by weakness, muscle atrophy and progressive paralysis and ends up with patients' death 2-5 years after diagnosis. Although these symptoms lead in many cases to gait deficits in patients, an exhaustive locomotor profile of animal models mimicking the disease has not been assessed yet. In this work we evaluated the locomotor performance of the SOD1(G93A) mouse model of ALS using computerized treadmill gait analysis. SOD1(G93A) mice presented early (8 weeks of age) gait abnormalities, evidenced by an increase in the time of the propulsion phase of hindlimb stance. The alterations progressed during the disease until a complete disturbance of normal gait. This finding is meaningful to the field because the identification of a significant difference in a functional endpoint as early as 8 weeks might be a step forward resolving the debate about treatment of mice prior to the symptomatic phase in efficacy studies. These results also point out that digitizing analysis of treadmill locomotion may be useful to evaluate whether new therapeutic approaches are improving functional outcome of the animals.

摘要

肌萎缩侧索硬化症(ALS)是一种神经退行性疾病,其特征是上下运动神经元的丧失。临床上,它表现为虚弱、肌肉萎缩和进行性瘫痪,最终导致患者在诊断后 2-5 年内死亡。尽管这些症状在许多情况下导致患者的步态缺陷,但尚未评估模拟疾病的动物模型的详尽运动学特征。在这项工作中,我们使用计算机化跑步机步态分析评估了 SOD1(G93A)ALS 小鼠模型的运动表现。SOD1(G93A)小鼠在 8 周龄时出现早期步态异常,表现为后肢支撑期推进相时间延长。随着疾病的进展,直到正常步态完全紊乱。这一发现对该领域具有重要意义,因为在 8 周时就确定功能终点的显著差异,可能是在疗效研究中在症状前阶段治疗小鼠的争论中向前迈出的一步。这些结果还表明,跑步机运动的数字化分析可能有助于评估新的治疗方法是否正在改善动物的功能结果。

相似文献

1
Evolution of gait abnormalities in SOD1(G93A) transgenic mice.SOD1(G93A)转基因小鼠步态异常的演变。
Brain Res. 2011 Aug 11;1406:65-73. doi: 10.1016/j.brainres.2011.06.033. Epub 2011 Jul 5.
2
Electrophysiological analysis of a murine model of motoneuron disease.运动神经元疾病小鼠模型的电生理分析。
Clin Neurophysiol. 2011 Aug;122(8):1660-70. doi: 10.1016/j.clinph.2011.01.045. Epub 2011 Feb 25.
3
Knocking down metabotropic glutamate receptor 1 improves survival and disease progression in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis.敲除代谢型谷氨酸受体 1 可改善肌萎缩侧索硬化症 SOD1(G93A)小鼠模型的生存和疾病进展。
Neurobiol Dis. 2014 Apr;64:48-59. doi: 10.1016/j.nbd.2013.11.006. Epub 2013 Dec 19.
4
Early motor and electrophysiological changes in transgenic mouse model of amyotrophic lateral sclerosis and gender differences on clinical outcome.肌萎缩侧索硬化症转基因小鼠模型的早期运动和电生理变化及临床结局的性别差异。
Brain Res. 2011 Jun 7;1394:90-104. doi: 10.1016/j.brainres.2011.02.060. Epub 2011 Feb 24.
5
Ablation of P2X7 receptor exacerbates gliosis and motoneuron death in the SOD1-G93A mouse model of amyotrophic lateral sclerosis.P2X7 受体消融加重肌萎缩侧索硬化症 SOD1-G93A 小鼠模型中的神经胶质增生和运动神经元死亡。
Hum Mol Genet. 2013 Oct 15;22(20):4102-16. doi: 10.1093/hmg/ddt259. Epub 2013 Jun 4.
6
Neuroprotective effects of JGK-263 in transgenic SOD1-G93A mice of amyotrophic lateral sclerosis.JGK-263对肌萎缩侧索硬化转基因SOD1-G93A小鼠的神经保护作用。
J Neurol Sci. 2014 May 15;340(1-2):112-6. doi: 10.1016/j.jns.2014.03.008. Epub 2014 Mar 12.
7
Metabolic progression markers of neurodegeneration in the transgenic G93A-SOD1 mouse model of amyotrophic lateral sclerosis.肌萎缩侧索硬化症转基因G93A-SOD1小鼠模型中神经退行性变的代谢进展标志物
Eur J Neurosci. 2007 Mar;25(6):1669-77. doi: 10.1111/j.1460-9568.2007.05415.x.
8
Optimal methods to characterize the G93A mouse model of ALS.表征肌萎缩侧索硬化症G93A小鼠模型的最佳方法。
Amyotroph Lateral Scler Other Motor Neuron Disord. 2005 Mar;6(1):55-62. doi: 10.1080/14660820510026162.
9
Significance of behavioural tests in a transgenic mouse model of amyotrophic lateral sclerosis (ALS).行为测试在肌萎缩侧索硬化症(ALS)转基因小鼠模型中的意义。
Behav Brain Res. 2010 Nov 12;213(1):82-7. doi: 10.1016/j.bbr.2010.04.042. Epub 2010 May 5.
10
High-speed video gait analysis reveals early and characteristic locomotor phenotypes in mouse models of neurodegenerative movement disorders.高速视频步态分析揭示了神经退行性运动障碍小鼠模型中早期和特征性的运动表型。
Behav Brain Res. 2016 Sep 15;311:340-353. doi: 10.1016/j.bbr.2016.04.044. Epub 2016 May 24.

引用本文的文献

1
A Longitudinal Study of Sex Differences in a TDP-43 Mouse Model Reveals STI1 Regulation of TDP-43 Proteinopathy and Motor Deficits.TDP-43小鼠模型中性别差异的纵向研究揭示了STI1对TDP-43蛋白病和运动缺陷的调节作用。
J Neurochem. 2025 Aug;169(8):e70204. doi: 10.1111/jnc.70204.
2
ALS-like pathology diminishes swelling of spinal astrocytes in the SOD1 animal model.在超氧化物歧化酶1(SOD1)动物模型中,肌萎缩侧索硬化症(ALS)样病理改变减轻了脊髓星形胶质细胞的肿胀。
Front Cell Neurosci. 2024 Oct 10;18:1472374. doi: 10.3389/fncel.2024.1472374. eCollection 2024.
3
AAV-NRIP gene therapy ameliorates motor neuron degeneration and muscle atrophy in ALS model mice.
腺相关病毒-核受体相互作用蛋白基因疗法改善了肌萎缩侧索硬化症模型小鼠的运动神经元变性和肌肉萎缩。
Skelet Muscle. 2024 Jul 24;14(1):17. doi: 10.1186/s13395-024-00349-z.
4
SERCA1 Overexpression in Skeletal Muscle Attenuates Muscle Atrophy and Improves Motor Function in a Mouse Model of ALS.在肌萎缩侧索硬化症小鼠模型中,骨骼肌中肌浆网Ca2+-ATP酶1过表达可减轻肌肉萎缩并改善运动功能。
J Neuromuscul Dis. 2024;11(2):315-326. doi: 10.3233/JND-230123.
5
The MT1 receptor as the target of ramelteon neuroprotection in ischemic stroke.MT1受体作为雷美替胺在缺血性卒中神经保护作用的靶点。
J Pineal Res. 2024 Jan;76(1):e12925. doi: 10.1111/jpi.12925. Epub 2023 Nov 20.
6
Intrathecal delivery of AAV-NDNF ameliorates disease progression of ALS mice.鞘内递送达菲肽(AAV-NDNF)可改善 ALS 小鼠的疾病进展。
Mol Ther. 2023 Nov 1;31(11):3277-3289. doi: 10.1016/j.ymthe.2023.09.018. Epub 2023 Sep 27.
7
Stride-level analysis of mouse open field behavior using deep-learning-based pose estimation.基于深度学习的姿势估计算法对小鼠旷场行为进行步伐水平分析。
Cell Rep. 2022 Jan 11;38(2):110231. doi: 10.1016/j.celrep.2021.110231.
8
Sigma-1 Receptor is a Pharmacological Target to Promote Neuroprotection in the SOD1 ALS Mice.西格玛-1受体是促进超氧化物歧化酶1型肌萎缩侧索硬化症小鼠神经保护的药理学靶点。
Front Pharmacol. 2021 Dec 10;12:780588. doi: 10.3389/fphar.2021.780588. eCollection 2021.
9
Anti-inflammatory Effects of a Novel Herbal Extract in the Muscle and Spinal Cord of an Amyotrophic Lateral Sclerosis Animal Model.一种新型草药提取物对肌萎缩侧索硬化症动物模型肌肉和脊髓的抗炎作用
Front Neurosci. 2021 Nov 11;15:743705. doi: 10.3389/fnins.2021.743705. eCollection 2021.
10
Locomotor deficits in a mouse model of ALS are paralleled by loss of V1-interneuron connections onto fast motor neurons.肌萎缩侧索硬化症(ALS)小鼠模型的运动缺陷与 V1 中间神经元与快肌运动神经元连接的丧失相平行。
Nat Commun. 2021 May 31;12(1):3251. doi: 10.1038/s41467-021-23224-7.